NCT04534816

Brief Summary

The surgical management of penetrating bowel and intestinal injuries, inflicted via a gunshot or knife stabbing, has long been a topic of debate \[1-3\]. The surgical management principally consists of: (i) primary repair; (ii) primary diversion or (iii) an initial abbreviated so called "damage control" operation followed by a definitive surgical intervention once the patient is stabilized \[4-9\] . Different classifications systems have been proposed to help determine the best operative option \[2,3,10-14\], but intestinal injuries can be difficult to manage and despite improvements in the diagnostics and treatment of penetrating abdominal trauma, high mortality and morbidity rates are prevalent \[15,16\]. In order to determine the correct surgical option an accurate determination of intestinal viability is essential. But clinically assessing regional perfusion is challenging and surgeons' clinical risk assessment of anastomotic leaks have shown a low predictive value \[17\]. Hence, there is a need for more precise diagnostic tool helping the surgeon in assessing intestinal viability the extent of intestinal injury. Indocyanine green (ICG) fluorescence angiography (ICG-FA) is an applied method for to assessing visceral perfusion worldwide. The obtained fluorescent signal after intravenous injection, is considered proportional to blood flow, thus aiding the surgeon to detect and address inadequate regional perfusion, despite satisfactory macroscopic appearance, intraoperatively \[18-21\]. Hence, the use of perioperative ICG-FA, has reduced the risk of anastomotic leaks after esophageal and colorectal surgery \[22-25\] and in the setting of acute mesenteric ischemia, significantly reduced the extent of intestinal resection \[26\]. In retrospective review of 186 war related trauma cases the use of ICG-FA was deemed useful however only 9 of these cases were truncal/abdomen/gastrointestinal and no objective definition of usability was provided \[27\]. Hence, data on the usability and feasibility of ICG-FA for in penetrating abdominal trauma is limited and to our knowledge has not been investigate in a civilian population previously. The present study aimed to investigate the usability and feasibility of ICG-FA in patients undergoing open abdominal exploration for penetrating abdominal trauma

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 12, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 24, 2020

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 1, 2020

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
Last Updated

November 30, 2020

Status Verified

November 1, 2020

Enrollment Period

6 months

First QC Date

August 24, 2020

Last Update Submit

November 25, 2020

Conditions

Keywords

ICGintestinal injurygunshot

Outcome Measures

Primary Outcomes (1)

  • Feasibility and usability of ICG-FA

    Feasibility is defined as the completion rates of the ICG angiography. For each ICG assessment, the operating surgeon will be asked to fill out the widely used System Usability Scale (SUS®).

    through study completion, an average of 1 year

Secondary Outcomes (1)

  • Surgical management

    through study completion, an average of 1 year

Study Arms (1)

Indocyanine Green

EXPERIMENTAL

patients abdominal injuries and repair will be investigated using Indocyanine Green

Diagnostic Test: Indocyanine Green

Interventions

Indocyanine GreenDIAGNOSTIC_TEST

Perfusion assessments

Indocyanine Green

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients (above 18 years) scheduled for emergency laparotomy due to penetrating abdominal trauma

You may not qualify if:

  • Allergy towards; iodine, indocyanine green or shellfish
  • Liver insufficiency
  • Thyrotoxicosis
  • Pregnancy or lactation
  • Legally incompetent for any reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tygerberg Hospital

Cape Town, South Africa

Location

Related Publications (1)

  • Patel MQ, Osterkamp JT, Buitendag JJ, Forgan TR, Steyn E. Indocyanine green fluorescence angiography in the management of intestinal injuries following penetrating abdominal trauma: a case-control study comparing postoperative outcomes. Int J Surg. 2024 Dec 1;110(12):7624-7629. doi: 10.1097/JS9.0000000000002096.

MeSH Terms

Conditions

Abdominal Injuries

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Michael P Achiam, DMSci

    Rigshospitalet, Denmark

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Pending patient acceptance all are eligible for inclusion
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D

Study Record Dates

First Submitted

August 24, 2020

First Posted

September 1, 2020

Study Start

March 12, 2020

Primary Completion

August 31, 2020

Study Completion

September 30, 2020

Last Updated

November 30, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations